Tau positivity

Biomarker1 paper

Latest

34

Journal of Alzheimer's DiseaseHumans1 Oct

Exploring the interplay between frailty, Alzheimer's disease biomarkers, and cognitive functioning in patients with mild cognitive impairment: A cross-sectional study

Mild cognitive impairment

JAMA NeurologyHumans21 Sep

A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease

Aging Medicine (Milton (N.S.W))Review3 Sep

Shared Metabolic-Proteinopathy Axis in Alzheimer's Disease and Parkinson's Disease: Evidence for a Convergent but Not Identical Disease Spectrum

Journal of Alzheimer's DiseaseHumans1 Sep

Cerebrospinal fluid homocysteine, but not plasma homocysteine, is associated with markers of tau pathology and neurodegeneration

medRxivHumansPreprint22 Aug

MRI-derived brain aging trajectories across the Alzheimer's continuum: links to cognition, pathology and lifestyle risk factors

Alzheimer's disease

European Archives of Psychiatry and Clinical NeuroscienceReview22 Aug

Diagnostic value of blood p-tau subtypes in Alzheimer's disease progression and pathology: systematic review and meta-analysis

Alzheimer's disease

AAIC 2025 AbstractHumans9 Jan

Synapse Protein Signatures in Cerebrospinal Fluid and Plasma Predict Cognitive Maintenance vs Decline in Alzheimer's Disease

AAIC 2025 AbstractHumans8 Jan

Harmonization of Flortaucipir, MK6240, PI2620 and RO948 with the Uniτ scale

AAIC 2025 AbstractHumans8 Jan

Plasma p ‐tau217 A+T+ status is associated with accelerated cognitive decline in the African Americans Fighting Alzheimer's in Midlife study

AAIC 2025 AbstractHumans8 Jan

Defining tau PET positivity grey zones for MK6240 and Flortaucipir quantification